DrugsControl Media Services
DrugsControl.org

News Detail

Many cancer drugs remain unproven 5 yrs after accelerated app (08-04-2024)

Washington, 8 April 2024: One hallmark of the FDA's accelerated approval pathway is the requirement that medicines prove their benefits in confirmatory trials. Now, new research shows that many cancer drugs approved under the pathway couldn't demonstrate survival benefits af......
View Details

Source : Fierce Pharma
U.S. Food and Drug Administration early approval to drugs fatal diseases drug companies rigorous testing clinical benefit confirmatory trials American Medical Association American Association for Cancer Research Health news

Related News